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Expiratory flow limitation (EFL) has been reported in pre-pubescent adolescents and 
elite, adult endurance athletes; however, the occurrence of EFL in elite adolescent 
endurance athletes has not been determined. Purpose: To determine incidence and 
severity of EFL in elite youth male cyclists of adolescent age. We hypothesized that elite, 
endurance trained youth will experience a higher prevalence and severity of EFL and 
dyspnea compared to an untrained control group. Pulmonary function will be similar pre- 
to post-exercise with bronchodilation occurring in both groups. Methods: 12 elite 
endurance- trained (ET) youth male cyclists (16.3 ± 1.0 years; 176.5 ± 6.2 cm; 64.2 ± 5.9 
kg) and 12 recreationally active males (CON) (17.6 ± 2.2 years; 177.9 ± 7.1 cm; 74.8 ± 
11.2 kg) completed an incremental test to exhaustion to determine peak oxygen 
consumption (VO2peak) on a cycle ergometer. Heart rate and ventilation (VE) were 
assessed throughout the exercise test. Dyspnea and ratings of perceived exertion (RPE) 
were assessed at the end of each stage. Subjects performed maximal flow volume loops 
(forced vital capacity (FVC), forced expiratory volume in 1-second (FEV1), FEV1/FVC, 
forced expiratory flow between 25-75% of FVC (FEF25-75%) and peak expiratory flow 
(PEF)) pre- and post- exercise. The occurrence and severity of EFL was quantified as the 
percentage of the expiratory tidal volume that overlapped with the maximum flow 
volume loop. Results: VO2peak in the ET group was 69.4±7.0 mL/kg/min and 45.7±3.9 
ml/kg/min in the CON group. Peak power (390 ± 57 W vs. 273 ± 45 W) and peak VE 
(158 ± 18 L/min) were higher in ET vs. CON (124.7 ± 15.3). The ET group experienced 
significant EFL at VO2peak (p < 0.001), with 11/12 subjects exhibiting flow limitation. In 





pulmonary function from pre- to post-exercise in FEV1 in both groups, with greater post-
exercise bronchodilation in the CON group. There was no change in FVC, FEV1/FVC, 
FEF25-75% of FVC or PEF. The ET cyclists also had higher dyspnea ratings and RPE at 
peak exercise (8.5 ± 1.2, p < 0.01; 18.5 ± 1.2) than CON (6.3 ± 2.6, 17.2 ± 1.6). 
Conclusions: Elite youth male cyclists have a higher occurrence of and severity of EFL 
at maximal exercise than recreationally active counterparts, which may limit exercise 
tolerance. Considering subjects are of pubertal age, or nearing the end of puberty, the 






Expiratory Flow Limitation in Elite Youth Cyclists 
Introduction: Pulmonary System as a Limiting Factor to Exercise Tolerance 
The pulmonary system does not typically limit exercise tolerance in untrained, 
adult men when exercising at sea level (Dempsey et al. 1984); the arterial partial pressure 
of oxygen (PO2) is maintained even during maximal exercise. Arterial PO2 closely 
matches alveolar PO2 since most people do not have a dramatic desaturation at maximal 
exercise; therefore, arterial PO2 is used as a proxy for alveolar PO2. There are some 
situations and population-specific exceptions, however, as pulmonary limitations have 
been reported in prepubescent children (Swain et al. 2010), women (Harms et al. 2006), 
the elderly (Johnson et al. 1994), diseased populations [(i.e. COPD patients (Pinto-Plata 
et al 2007)], and highly trained athletes (Mota et al 1999).   
The partial pressure of arterial carbon dioxide (PaCO2) is regulated by increasing 
ventilation rates during exercise.  Specifically, an increase in tidal volume and breathing 
frequency contribute to ventilation and regulation of PaCO2. Tidal volume (TV) is the 
first component to increase for higher ventilatory rates, due to the increases in end-
inspiratory lung volume (EILV) and decreases in end-expiratory lung volume (EELV) 
(Aliverti 2008). TV increases during heavy exercise until it plateau’s between 50-60% of 
vital capacity. Any increase in ventilation following that plateau comes from an increase 
in breathing frequency (BF) (Sheel et al. 2008). Under most conditions this increase in 
ventilation can be facilitated by the pulmonary system even during maximal exercise 
given the large ventilatory reserve (Aliverti 2008). However, expiratory flow limitation 




expiratory portion of the maximal-flow volume loop (Johnson et al. 1999). The 
expiratory flow limitation (EFL) and the connected hyperinflation of the lungs that occurs 
to avoid the expiratory portion of the maximal flow-volume loop presents a notable 
limitation in the pulmonary system, ultimately decreasing exercise tolerance by 
increasing dyspnea, exercise induced arterial hypoxemia (EIAH), and RMF (Babb et al. 
1991). Dynamic hyperinflation increases inspiratory muscle work and may subsequently 
impair the function of inspiratory muscles (Mota 1999). The reduced dynamic lung 
compliance then causes an increased work of breathing which can ultimately limit 
exercise performance (McKenzie 2018).  This inability to increase ventilation is 
associated with exercise-induced arterial hypoxemia (EIAH) (Johnson 1992), which will 
be discussed later.  
EFL is caused by morphological limitations and can be exacerbated by 
differences in chemoreceptor sensitivity. The chemoreceptors sense changes in O2 and 
CO2 in the blood returning from limb locomotor muscles during exercise (Dempsey 
2014). However, EFL also occurs due to the structural limitations of the lungs and 
airways, in which they can no longer keep up with the demands of exercise. The lungs 
and airways reach a limit where they cannot inflate any more than they already are, 
therefore, the individual’s anatomy limits the ability of the lungs to generate higher flow 
(Harms and Rosenkranz 2006).     
 Therefore, EFL can be explained by both the inability of the lungs and airways to 
meet the ventilatory demands of exercise, as well as the lack of responsiveness in 




maximal ventilation during exercise is limited by EFL (Mota 1999). When EFL occurs, 
subsequent consequences such as dyspnea, RMF, EIAH may also occur.  
Dyspnea  
Dyspnea is defined as uncomfortable sensations while breathing (American 
Thoracic Society). At maximal exercise, severe dyspnea occurs and decreases an 
individual’s exercise tolerance (Weavil 2002). Weavil et al. found that when an 
individual experiences high levels of EFL during exercise, dynamic hyperinflation (DH) 
occurs and its implication is a feeling of breathlessness that can impair exercise tolerance. 
Interestingly, when flow limitation was imposed with a Starling resistor, severe dyspnea 
was experienced along with a 65% decrement in exercise performance, compared to the 
control trial without flow limitation and no dyspneic sensation (Iandelli 2002). While 
initial studies thought there was a strong connection between dyspnea and DH 
occurrence, recent studies have shown that dyspnea and exercise intolerance is actually 
associated more with EILV increases during exercise than DH (Calligaro; Guenette 
2012). 
Dynamic Hyperinflation and Respiratory Muscle Fatigue  
When EELV increases above FRC and EILV increases near total lung capacity 
(TLC), it is termed dynamic hyperinflation (Johnson et al. 1999). EFL-induced DH has 
several consequences that can ultimately limit exercise tolerance. These consequences 
include dyspnea, RMF, constrained ventilation and gas exchange impairments. EFL may 
also cause EIAH to occur, especially in women who are more likely to experience EFL 
(Walls et al. 2002). EFL can cause inadequate hyperventilation and other altered 




et al. 2008). When DH occurs, expiratory work increases, resulting in airway closure that 
contributed to decreases in expiratory flow (Mota et al. 1999). DH has also been 
associated with dyspnea and impaired exercise tolerance (Pellegrino et al. 1993). While 
DH has been well-studied as a severe consequence of EFL, there is conflicting data 
regarding whether DH is the main factor limiting exercise tolerance. For example, 
Iandelli et al found that DH did not lead to impaired exercise tolerance in two of their six 
subjects when EFL was externally applied. DH did not contribute to dyspnea in their 
other four subjects until they achieved the highest severity of EFL in the exercise bout 
leading to their conclusion that DH may be overemphasized by some researchers in its 
role with exercise tolerance (Iandelli et al. 2002). In addition to EFL leading to possible 
DH and dyspnea, DH can also contribute to respiratory fatigue. 
During higher intensities of exercise the respiratory muscles are recruited to a 
greater extent. At an intensity of greater than 80% of VO2max for ~3-5 min, diaphragmatic 
fatigue may occur (Babcock et al. 1995). When diaphragmatic fatigue occurs, the 
inspiratory muscle metaboreflex is initiated to vasoconstrict blood from the working limb 
locomotor muscles to the diaphragm (Wetter et al. 1999). The respiratory muscles 
demand more blood flow to prevent respiratory muscle fatigue. Harms et al. estimated 
that 14-16% of cardiac output during maximal exercise is shunted to the respiratory 
muscles (Harms, 2000). Vogiatzis et al found that the inspiratory muscle metaboreflex is 
initiated between 60-80% of maximal intensity exercise and then plateaued; blood flow to 
the respiratory muscles dropped off at maximal intensity exercise. They concluded that 
the demands of exercise placed on the respiratory system and working skeletal muscle 




2009). This shift in blood can limit exercise performance due to the skeletal muscle 
receiving less blood compared to the respiratory muscles (Aliverti 2008). Likewise, 
Harms et al. concluded that respiratory muscles can impact exercise tolerance when the 
workload is strenuous due to blood flow being redirected from the locomotor muscles to 
the respiratory muscles (Harms 2000). Regarding exercise intensity, Smith et al. reported 
that significant respiratory muscle fatigue occurred at 85% of VO2max, but not at 70% of 
VO2max (Smith et al. 2014). This finding suggests that when athletes perform high 
intensity exercise the inspiratory muscle metaboreflex is initiated, which may lead to 
respiratory muscle fatigue. As mentioned previously, when EFL and DH are present, the 
oxygen cost of breathing increases (Johnson et al. 1999). The additional oxygen cost of 
breathing that results from DH can exacerbate exercise intolerance that was caused by 
pre-existing respiratory muscle fatigue and the inspiratory muscle metaboreflex. 
Special Populations 
Previous research has shown that EFL tends to affect specific populations. 
Prepubescent children in the United States have a high prevalence of EFL and EIAH. 
Children experience EFL due to their smaller lungs that are still developing, dysynaptic 
growth between the lungs and airways, and because their ventilation is higher at any 
given metabolic rate (Robben et al. 2013). Children have higher chemoreceptor 
sensitivity and regulate CO2 at lower levels than adults. EFL is prevalent in 70-93% of 
untrained children (Emerson et al. 2015). In addition to the high prevalence of EFL 
among prepubescent children, aerobic training performed by prepubescent children may 
lead to greater ventilatory constraints (Nourry et al. 2005). However, the only 




puberty the prevalence of EFL decreases (Emerson et al. 2015). Emerson and colleagues 
state that this is most likely due to the pulmonary system further developing with 
maturation (Emerson et al. 2015). 
In addition to the high prevalence of EFL in children, women also have a higher 
prevalence of EFL compared to men (Johnson et al. 1993). This usually occurs because 
of mechanical constraints due to differences in lung size, which limit the overall function 
of the pulmonary system. Also, women have less alveoli due to their smaller lungs which 
decreases the total surface area for diffusion (Mead, 1980). Women also have airway 
diameters that are smaller relative to their lung size compared to males leading to a lower 
dysynapsis ratio, which is associated with a greater prevalence of EFL (Mead, 1980). 
Women have a higher work of breathing compared to males due to a greater resistive 
work in the airways (Sheel et al. 2016). All of these limitations play a role in the presence 
and severity of EFL in women.  
Patients with pulmonary disorders are also at risk for suffering from EFL. A study 
on patients with cystic fibrosis found that EFL presence in resting tidal volume could 
predict significant deterioration in lung function two years after its onset (Vilozni et al. 
2016). The elderly population has also been shown to be affected by EFL due to the loss 
of elastic recoil of the lungs and airways with age, along with increased dead space at rest 
and during exercise (Turner et al. 1968, McKenzie, 2012).  
Finally, elite adult athletes also display EFL. EFL occurs during severe intensity 
exercise in many highly trained endurance athletes and other subpopulations (Aliverti 
2008, Mota et al. 1999, McKenzie 2012). Highly trained endurance athletes may intersect 




become flow-limited (Aliverti 2008). While elite athletes have training adaptations to the 
cardiovascular and musculoskeletal systems, they do not have training adaptations to the 
pulmonary system in order to compensate for flow limitation (McKenzie 2012). The 
pulmonary system can be considered “underbuilt” compared to other systems due to its 
inability to adapt to training. Therefore during heavy intensity exercise, the mechanical 
constraints from the lungs size can limit the maximal inflation of their lungs, which 
training does not impact (Derchak 2000). Due to the increased metabolic and respiratory 
demand, the higher work of breathing during heavy exercise, concomitant hyperinflation, 
trained athletes often experience EFL which limits exercise tolerance (McKenzie 2012). 
Significance 
While EFL is present in the populations previously mentioned, the prevalence of 
EFL in elite, endurance-trained adolescents has yet to be addressed. Adolescents present 
a unique challenge due to their physiology. Previous studies have found that 
prepubescent children tend to “outgrow” their flow limitation once puberty is reached 
(Emerson 2015). Considering the prevalence of EFL is high in trained aerobic adult 
athletes, elite, adolescent cyclists are an interesting population. Throughout adolescence, 
the lungs and the airways may still be growing, and therefore the pulmonary system may 
pose a notable limitation. Therefore, the primary purpose of this study is to determine 
whether elite, endurance-trained adolescents experience EFL to a greater extent that age 
and lung-size matched counterparts. A secondary purpose is to examine whether 
subsequent consequences of EFL will be higher in the trained adolescents compared to 




experience EFL and its subsequent consequences to a greater extent and at a higher 
severity than their untrained peers.  
In understanding the prevalence of EFL in elite adolescent cyclists compared to 
untrained age-matched non-endurance trained counterparts, we will gain a better 
understanding of how the pulmonary system contributes to impaired exercise tolerance in 
























Twenty-four male subjects between the ages of 13 and 19 were recruited to 
participate in the study. The study was composed of an experimental group, consisting of 
elite, youth endurance-trained (ET) cyclists (n=12) and a control group (CON) of non-
endurance trained, recreationally active subjects (n=12). The CON group were matched 
for age, height, and absolute lung size (e.g. forced vital capacity) with the ET group. All 
procedures were approved by the James Madison University Institutional Review Board 
and parental consent and youth assent was obtained prior to data collection. 
Experimental Design 
Following height, weight, and body composition measurements (Dual-energy X-
Ray Absorptiometry (DEXA)), subjects performed maximal flow volume loops (MFVLs) 
on a SensorMedics 229 Metabolic Cart (SensorMedics Corp., Yorba Linda, Calif., USA). 
This pulmonary function test is the gold standard to assess the maximum capacity of the 
pulmonary system. Following the MFVL’s, participants completed a maximal exercise 
test on a Velotron cycle ergometer (Velotron, Seattle, Washington, USA) until they 
reached volitional fatigue. At the end of each stage during the exercise test, inspiratory 
capacity (IC) maneuvers were performed. Immediately following the exercise test, the 
MFVLs were repeated.  
Body Composition  
Height was taken to the nearest 0.1 inch using a portable stadiometer (Invicta 




to the nearest 0.1 kg using a standard physician’s scale (Pelouze 4040; Health o meter, 
Inc., Bridgeview, Illinois, USA). Next, the subject underwent a DEXA scan (Lunar 
iDXA, General Electric Company, Boston, Massachusetts, USA). For the DEXA scan, 
the subject laid supine for approximately 7-10 min until assessment of fat mass, fat free 
mass, and bone mineral density was completed. 
Pulmonary Function Measures 
All participants were given verbal prompts during these tests and were 
encouraged throughout the tests by the primary investigators. The subjects performed 
MFVLs pre- and post-exercise. All tests administered adhered to the ATS/ERS guidelines 
(Miller et al. 2005). Knudson (1983) reference values were used to calculate percent of 
predicted lung function. To achieve an acceptable MFVL, (1) the expiratory volume in 
FEV1 must be <5% of the FVC or 0.150 L, whichever is greater; (2) there must be no 
cough during the first second of the expiratory portion; (3) the participant does not inhale 
too early (test does not terminate early); (4) there is no hesitation during the maneuver 
which may preclude an accurate measurement of FEV1 and FVC; (5) there is no leak or 
obstruction in the mouthpiece and (6) the maneuver is performed correctly without an 
extra breath taken. In addition, the largest MFVL was used to assess EFL presence and 
severity. From the MFVL we obtained the values for forced expiratory volume in one 
second (FEV1), forced vital capacity (FVC), FEV1/FVC, peak expiratory flow (PEF), and 
forced expiratory flow at 25-75% of FVC (FEF25-75%).  
Cardiopulmonary Exercise Testing 
A graded exercise test was performed until exhaustion to determine peak oxygen 




Ratings of perceived exertion (RPE) and dyspnea were reported during each stage of the 
test. The ET group started at a self-selected wattage based on their previous training and 
the CON group started at 50 watts. The workload increased for both groups by 25 every 3 
min until lactate threshold was reached. Lactate threshold was determined by finger 
sticks at the end of every 3-min stage using a Lactate Pro lactate analyzer (Arkray, Inc., 
Shiga, Japan). After lactate threshold was reached the subjects began the incremental 
protocol for the maximal exercise test at the wattage in the stage before lactate threshold 
was reached. In the incremental protocol, watts increased by 25 every min until volitional 
exhaustion was reached. At the end of each one-min stage subjects were asked to rate 
their dyspnea using the Dyspnea Numeric Rating Scale and RPE using Borg’s 6-20 point 
scale. All subjects wore a PolarLink heart rate monitor (Bethpage, NY) throughout the 
entire test, and heart rate was recorded during the last 20 s of each stage. Ventilatory and 
metabolic data were recorded throughout the entire test.  
Expiratory Flow and Tidal Volume Assessment 
Tidal volume (VT) was assessed through a bidirectional flow sensor during the 
VO2peak test. During the VO2peak test, inspiratory capacity (IC) maneuvers were performed 
during the last ~20 seconds of each one-min stage of exercise. The tidal flow-volume 
loops were placed inside the largest MFVL. We allowed for ~5 tidal volume loops to 
appear before the subject performs the IC maneuver to ensure end-expiratory lung 
volumes were consistent. The IC maneuvers were then placed within the post-exercise 
MFVL to assess EFL presence and severity. The subjects were given instruction on how 
to perform the IC maneuver and required to practice the maneuver at baseline before the 




tidal flow-volume loop with the expiratory portion of the MFVL by 5% of greater. A 
secondary investigator blinded to the initial calculations verified the percent of 
intersection initially measured by the primary investigator. If the measurements differed 
by >5%, a third investigator assessed the percent of the intersection and the closest two 
were averaged for analysis.  
Statistical Analysis 
Statistical analyses for this study was performed using SPSS v.24.0. All data was 
be checked for normality using the Shapiro-Wilk test to ensure parametric assumptions 
were met. Data was expressed as mean ± SD in tables and mean ± SE in figures. A 2x2 
mixed ANOVA (time versus group) was used to determine differences pre- and post-
exercise between the ET group and CON group. Significance was set to p < 0.05 for all 
analyses. Bonferroni adjustments were used to account for multiple comparisons. 
Pearson-product moment correlation coefficient was used to measure associations 
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Expiratory flow limitation (EFL) has been reported in pre-pubescent adolescents and 
elite, adult endurance athletes; however, the occurrence of EFL in elite adolescent 
endurance athletes has not been determined. Purpose: To determine incidence and 
severity of EFL in elite youth male cyclists of adolescent age. We hypothesized that elite, 
endurance trained youth will experience a higher prevalence and severity of EFL and 
dyspnea compared to an untrained control group. Pulmonary function will be similar pre- 
to post-exercise with bronchodilation occurring in both groups. Methods: 12 elite 
endurance- trained (ET) youth male cyclists (16.3±1.0 years; 176.5±6.2 cm; 64.2±5.9 kg) 
and 12 recreationally active males (CON) (17.6±2.2 years; 177.9±7.1 cm; 74.8±11.2 kg) 
completed an incremental test to exhaustion to determine peak oxygen consumption 
(VO2peak) on a cycle ergometer. Heart rate and ventilation (VE) were assessed throughout 
the exercise test. Dyspnea and ratings of perceived exertion (RPE) were assessed at the 
end of each stage. Subjects performed maximal flow volume loops (forced vital capacity 
(FVC), forced expiratory volume in 1-second (FEV1), FEV1/FVC, forced expiratory flow 
between 25-75% of FVC (FEF25-75%) and peak expiratory flow (PEF)) pre- and post- 
exercise. The occurrence and severity of EFL was quantified as the percentage of the 
expiratory tidal volume that overlapped with the maximum flow volume loop. Results: 
VO2peak in the ET group was 69.4±7.0 mL/kg/min and 45.7±3.9 ml/kg/min in the CON 
group. Peak power (390 ± 57 W vs. 273 ± 45 W) and peak VE (158 ± 18 L/min) we 
higher in ET vs. CON (124.7 ± 15.3). The ET group experienced significant EFL at 
VO2peak (p < 0.001), with 11/12 subjects exhibiting flow limitation. In the CON group, 




pre- to post-exercise in FEV1 in both groups, with greater post-exercise bronchodilation 
in the CON group. There was no change in FVC, FEV1/FVC, FEF25-75% of FVC or PEF. 
The ET cyclists also had higher dyspnea ratings and RPE at peak exercise (8.5 ± 1.2, p < 
0.01; 18.5 ± 1.2) than CON (6.3 ± 2.6, 17.2 ± 1.6). Conclusions: Elite youth male 
cyclists have a higher occurrence of and severity of EFL at maximal exercise than 
recreationally active counterparts, which may limit exercise tolerance. Considering 
subjects are of pubertal age, or nearing the end of puberty, the participants may outgrow 
their flow limitation.     
The pulmonary system does not usually limit exercise tolerance in untrained, 
adult men when exercising at sea level (Dempsey et al. 1984). Under most conditions, the 
increase in ventilation can be maintained by the pulmonary system even during maximal 
exercise since there is large ventilatory reserve that can be utilized (Aliverti 2008). 
However, in specific populations, the pulmonary system may be a limitation during 
prolonged exercise and maximal exercise. Specifically, a condition called expiratory flow 
limitation (EFL; constrained ventilation) may occur in prepubescent children, women, 
elite adult endurance athletes, pulmonary disease patients, and the elderly, and it is 
characterized by a tidal volume (VT) that approaches and intersects the expiratory portion 
of the maximal-flow volume loop (Johnson et al. 1999). The EFL and the associated 
hyperinflation of the lungs that occurs to avoid the expiratory portion of the maximal 
flow-volume loop presents a notable limitation in the pulmonary system, ultimately 
decreasing exercise tolerance (Babb et al. 1991).  
In heavy endurance exercise, ventilatory requirements are extremely high to meet 
the metabolic demands of exercise. While this increase in metabolic demand is placed on 
the lungs, the total capacity of the lungs and chest wall to generate flow and increase 
volume does not adapt with exercise training, and therefore the total ventilatory capacity 
is not different between trained and untrained individuals.  In addition, several studies 
have suggested that highly trained individuals have altered chemoreceptor sensitivity and 
therefore lack and adequate hyperventilatory response to maximal exercise (Johnson 
1992). Therefore, the lungs and airways reach a limit where they cannot inflate beyond 
their existing capacity, and this structural limitation precludes individuals from 




ventilation during exercise is limited by EFL (Mota et al. 1999). In addition, the 
regulation of lung volumes [end-inspiratory lung volume (EILV) and end-expiratory lung 
volume (EELV)] also affects ventilatory constraint during exercise. When EELV 
increases above functional residual capacity (FRC) and EILV increases near total lung 
capacity (TLC), it is termed dynamic hyperinflation (DH) (Johnson et al. 1999). The 
presence of EFL and subsequent DH can limit exercise tolerance by increasing dyspneic 
sensations (Weavil et al. 2015), respiratory muscle fatigue (Dempsey et al. 2008) and gas 
exchange impairments (Weavil et al. 2015).  
While EFL has been reported in specific populations, such as women (McClaran 
et al. 1998), older adults (Smith et al. 2017), pre-pubescent children (Swain et al. 2010, 
Smith et al. 2015), and endurance trained athletes (Johnson et al. 1992), the prevalence of 
EFL in elite, endurance-trained youth cyclists, has yet to be studied. Previous studies 
have found that prepubescent, recreationally active youth tend to “outgrow” their flow 
limitation once puberty is reached (Emerson et al. 2015). Still, while elite endurance 
athletes have training adaptations to the cardiovascular and musculoskeletal systems, 
their pulmonary system does not appear to adapt in a manner that can compensate for 
flow limitation (McKenzie, 2012). Considering the prevalence of EFL is high in 
aerobically trained adult athletes, elite youth cyclists of pubertal age are an interesting 
population to be studied. Moreover, given that the lungs and airways of youth endurance 
athletes may not have reached full development, yet the ventilatory and metabolic 
requirements are extremely high in heavy endurance exercise, the pulmonary system may 
pose a notable limitation to meet the demands of heavy exercise. Therefore, the primary 




endurance-trained (ET) youth cyclists of pubertal age compared to their age, height, and 
lung-size matched counterparts. The secondary purpose was to examine whether 
pulmonary function and dyspnea will be different during exercise in the ET group 
compared to an untrained control (CON) group. We predict that the ET youth cyclists 
will experience a higher prevalence and greater severity of EFL and dyspnea compared to 
CON group, however pulmonary function will be similar from pre- to post-exercise with 






















Twenty-four male subjects between the ages of 13 and 19 were recruited to 
participate in the study. The study was composed of an experimental group, consisting of 
elite, endurance trained (ET) youth cyclists (n=12), and a CON group of non-endurance 
trained recreational cyclists (n=12). The CON group were matched for age, height, and 
absolute lung size (e.g. forced vital capacity) with the ET group. All procedures were 
approved by the James Madison University Institutional Review Board and parental 
consent and youth assent was obtained prior to data collection.  
Experimental Design 
Following height, weight, and body composition measurements [Dual-energy X-
Ray Absorptiometry (DEXA)], subjects performed maximal flow volume loops (MFVL) 
on a SensorMedics 229 Metabolic Cart (SensorMedics Corp., Yorba Linda, Calif., USA). 
This pulmonary test is the gold standard to assess the maximum capacity of the 
pulmonary system. Following the MFVL’s, participants completed a maximal exercise 
test on a Velotron cycle ergometer (Velotron, Seattle, Washington, USA) until they 
reached volitional fatigue (described below). At the end of each stage during the exercise 
test, inspiratory capacity (IC) maneuvers were performed. Immediately following 
volitional fatigue, the MFVLs were repeated.  
Anthropometrics  
Height was taken to the nearest 0.1 inch using a portable stadiometer (Invicta 
Height Measure; Invicta Plastics Limited, Leicester, England, UK) and weight was taken 




Inc., Bridgeview, Illinois, USA). Next, the subject underwent a DEXA scan (Lunar 
iDXA, General Electric Company, Boston, Massachusetts, USA). For the DEXA scan, 
the subject laid supine for approximately 7-10 min until assessment of fat mass, fat free 
mass, and bone mineral density was completed. 
Pulmonary Function Measures 
All participants were given verbal prompts during this test and were encouraged 
throughout the test by the primary investigators. The subjects performed MFVLs pre- and 
immediately post-exercise. All of the pulmonary function tests that were administered 
adhered to the ATS/ERS guidelines (Miller 2005). Knudson (1983) reference values were 
used to calculate percent of predicted lung function. To achieve an acceptable maximum 
flow volume loop (MFVL): (1) the expiratory volume in FEV1 must be <5% of the FVC 
or 0.150 L, whichever is greater; (2) there must be no cough during the first second of the 
expiratory portion; (3) the participant does not inhale too early (test does not terminate 
early); (4) there is no hesitation during the maneuver which may preclude an accurate 
measurement of FEV1 and FVC; (5) there is no leak or obstruction in the mouthpiece and 
(6) the maneuver is performed correctly without an extra breath taken. In addition, the 
largest MFVL was used to assess EFL presence and severity. From the MFVL we 
obtained the values for forced expiratory volume in one second (FEV1), forced vital 
capacity (FVC), FEV1/FVC, peak expiratory flow (PEF), and forced expiratory flow at 
25-75% of FVC (FEF25-75%).  
Cardiopulmonary Exercise Testing 
A graded exercise test was performed until exhaustion to determine VO2peak on a 




dyspnea were reported during each stage of the test. The ET group started at a self-
selected wattage based on their previous training and the CON group started at 50 W. The 
workload increased for both groups by 25 W every 3-min until lactate threshold was 
reached. Lactate threshold was determined by finger sticks at the end of every 3-min 
stage using a Lactate Pro lactate analyzer (Arkray, Inc., Shiga, Japan). After lactate 
threshold was reached the subjects began the incremental protocol for the maximal 
exercise test at the wattage in the stage before lactate threshold was reached. In the 
incremental protocol, workload increased by 25 W every minute until volitional 
exhaustion was reached. At the end of each one-min stage subjects were asked to rate 
their dyspnea using the Dyspnea Numeric Rating Scale and RPE using Borg’s 6-20 point 
scale. All subjects wore a PolarLink heart rate monitor (Bethpage, NY) throughout the 
entire test, and heart rate was recorded during the last 20 seconds of each stage. 
Ventilatory and metabolic data were recorded throughout the entire test.  
Expiratory Flow and Tidal Volume Assessment 
Tidal volume (VT) was assessed through a bidirectional flow sensor during the 
VO2peak test. Prior to the VO2peak test, subjects were given instruction on how to perform 
the inspiratory capacity (IC) maneuver and were required to practice the maneuver at 
baseline. During the VO2peak test, IC maneuvers were performed during the last ~20 
seconds of each one-min stage of exercise. We allowed for ~5 tidal volume loops to 
appear before the subject performed the IC maneuver to ensure end-expiratory lung 
volumes were consistent. The IC maneuvers were then superimposed within the post-
exercise MFLV to assess EFL presence and severity. EFL was determined by the percent 




5% or greater. A secondary investigator blinded to the initial calculations verified the 
percent of intersection initially measured by the primary investigator. If the 
measurements differed by >5%, a third investigator assessed the percent of the 
intersection and the closest two were averaged for analysis. To assess EFL severity at 
specific exercise intensities, the VO2 value that was closest to the correct intensity for 
each subject at 20%, 40%, 60%, 80% or 100% of VO2peak, was used for the analysis. 
Assessing EFL severity over a relative range of values dependent on individual subjects 
responses during exercise has previously been used in the literature to measure EFL 
severity and operative lung volumes as a % of VO2peak (Emerson et al. 2014, Guenette 
et al. 2010), or EFL severity and operative lung volumes over various ventilations (Smith 
et al 2017).  
Statistical Analysis 
Statistical analyses for this study were performed using SPSS v.24.0. All data was 
checked for normality using the Shapiro-Wilk test to ensure parametric assumptions were 
met. Data were expressed as mean ± SD in tables and mean ± SE in figures. A 2x2 mixed 
ANOVA (time versus group) was used to determine differences pre- and post-exercise 
between the ET group and CON group for EFL severity and changes in operating lung 
volumes. Significance was be set to p < 0.05 for all analyses. Bonferroni adjustments 
were used to account for multiple comparisons. Pearson-product moment correlation 
coefficient were used to measure associations between severity of EFL, ventilation and 










Subject characteristics are shown in Table 1. The ET group were matched to the 
CON group by age (p = 0.085), height (p = 0.616) and FVC (p = 0.225). There was a 
significant difference between the two groups for weight (p = 0.009) and body fat 
percentage (p = 0.006). Maximal exercise and ventilatory values from the VO2peak test are 
shown in Table 2. At VO2peak, the CON group had significantly lower absolute VO2, 
relative VO2, peak power, peak VE and VCO2. Subjects in the CON group had significantly 
lower dyspneic ratings (p = 0.014) and RPE (p = 0.035) at peak exercise, but significantly 
higher RER values (p = 0.001).  
Expiratory Flow Limitation 
EFL at 20, 40, 60, 80, and 100% of VO2peak is shown in Figure 1. Both ET and CON 
had significantly increased EFL severity from baseline to peak exercise (p < 0.001), 
however the ET group experienced a higher severity of EFL from baseline to peak exercise 
(p = 0.001). Specifically, 11/12 subjects in the ET group were flow-limited and 5/12 in the 
CON group were flow limited, with 75.0 ± 32.9 % of EFL severity in the ET and 29.7 ± 
40.4% of EFL severity in the CON group.  
Pulmonary Function 
Pulmonary function measurements are shown in Table 3. There were no significant 
differences in absolute lung volumes or flow rates between the ET and CON at baseline. 
From pre- to post-exercise, both groups significantly increased FEV1 (p = 0.002), 
FEV1/FVC (p < 0.001), FEF25%-75% of FVC (p < 0.001), however there was no significant 




there was a significant interaction between the ET and CON groups over time in FEV1 (p 
= 0.025), however not in FVC, FEV1/FVC, FEF25%-75% of FVC, or PEF.  
Operating Lung Volumes 
        Operating lung volumes (EILV and EELV) in CON and ET subjects are displayed in 
Figure 2 as a percentage of FVC. EELV decreased from baseline (36.5 ± 8.1% of FVC), at 
20% (37.5 ± 9.7% of FVC) at 40% (34.9 ± 8.9% of FVC), 60% (34.8 ± 7.2% of FVC), 
80% (34.7 ± 6.6% of FVC) and 100% of VO2peak (34.4 ± 7.8% of FVC), however changes 
were not significant as a main effect of time (p = 0.219) or between ET and CON across 
time (p = 0.206). There were significant increases in EILV across time points (p < 0.001) 
from baseline (59.8 ± 10.3% of FVC) to 100% of VO2peak (87.9 ± 7.9% of FVC), but no 
difference in EILV between the ET and CON groups across time (p = 0.742).  
Ventilatory Responses to Exercise, EFL and Subsequent Outcomes 
     The present study found no associations between EFL and ventilation, dyspnea ratings, 
or RPE at VO2peak (Figures 3A-C). In addition, there was no association between the change 
in FEV1 from pre- to post-exercise (r = -0.025, p = 0.909), or EFL with body fat percentage 
(r = -0.217, p= 0.303). Also, there was a significant increase in VE/VCO2 across time, 
however there was not a significant interaction between the ET and CON groups across 
time (p = 0.895). There was a significant increase in VE/VO2 throughout the exercise 
protocol (p < 0.001), however there was not a significant interaction between the ET and 









This study investigated the prevalence and severity of EFL in elite, ET youth 
cyclists, in comparison to recreationally active untrained CON subjects matched by age, 
height, and lung-size (FVC). Our major finding was that the ET group had a greater EFL 
prevalence and severity than the CON group. In addition, post-exercise bronchodilation 
differed between the CON and ET groups, though it did not appear to be associated with 
EFL. Operating lung volumes were not different between the ET and CON groups, 
however EILV increased during exercise in both groups.  Finally, though not associated 
with EFL severity, dyspnea ratings were higher in the ET group at peak exercise.  
EFL Presence and Severity in Trained vs Untrained Subjects 
There was a greater prevalence of EFL in the ET group, and a greater severity of 
EFL at peak exercise in the ET group compared to the CON group. While this is in 
agreement with the previous literature showing most (> 90%) endurance trained adult 
males have EFL (Johnson et al.), Emerson et al. conducted a longitudinal study that 
reported that untrained, adolescent subjects of similar age (15.3 ± 0.5 y) to the subjects in 
the present study (16.9 ± 1.8 y) tend to outgrow their flow-limitation. Specifically, 
Emerson et al. reported that 10 of 11 pre-pubertal boys exhibited EFL at VO2max. Five 
years later, only 5 of these 11 subjects (measured post-pubertal) exhibited EFL at VO2max.  
In the present study, 11 out of 12 elite, ET cyclists exhibited EFL. These findings 
are consistent with several studies in endurance trained adult athletes, however the 
prevalence of EFL in endurance trained adult athletes is not consistent in the existing 




of 10 competitive cyclists exhibited EFL at peak exercise. However, subjects in their 
study were 21 ± 5 years of age, and likely had reached full maturation. Therefore, 
discrepancies between the present study and Mota et al.’s work may be explained by 
maturation stage of the subjects. Yet differences may also exist due to the study 
methodology utilized for the assessment of EFL. Specifically, Mota et al. assessed 
endurance trained young adults by applying negative expiratory pressure at the mouth, 
where we used the overlap method that has been validated in many studies (Johnson et al. 
1999, Smith et al. 2014, Chenoweth et al. 2015, Smith 2017). While both methods are 
acceptable and commonly used, not accounting for thoracic gas compression in the 
present study may overestimate the severity of EFL experienced (discussed in the 
limitations section) (Guenette et al. 2010). While differences exist in the study 
methodology, there are similarities in VO2max scores between subjects in both studies (72 
± 6 mL/kg/min in Mota and 69 ± 7 mL/kg/min in the present study) as well as similar 
ventilation at VO2max (147 ± 20 L/min and 157.5 ± 18.1 L/min, respectively). Taken 
together, these findings suggest that differences in reported EFL presence are due to 
either methodological differences and/or differences in lung size due to maturation stage, 
since age was different but not fitness level of the endurance athletes. 
While Mota and colleagues suggest flow limitation is not prevalent in endurance 
trained athletes, several research studies report that EFL prevalence and severity is 
moderate-high in this unique population (Nourry et al. 2005, Johnson et al. 1992). 
Johnson and colleagues have found that 4/8 adult endurance runners exhibited EFL at 
peak exercise, yet another study reports most endurance trained cyclists exhibit EFL at 




could be partly due to the impact cycling posture has on operating lung-volumes in the 
riding position, which has recently been reported by Duke et al. (2014). However, the 
impact of different riding positions on EFL has yet to be determined in youth. While the 
literature reporting EFL presence is conflicting, it may be possible for endurance athletes 
to outgrow their flow limitation once they have reached full maturation. However, it is 
clear that not all individuals outgrow their flow limitation based on the prevalence of this 
phenomenon in highly fit adult athletes. Without a longitudinal study that follows the 
same cohort of endurance athletes from puberty into adulthood, we cannot determine 
whether these specific athletes will outgrow their flow limitation. 
Interestingly, the only time point at which EFL severity was different between the 
CON and ET group was at peak exercise, which is supported by the existing literature 
where EFL has been reported in endurance trained adults. Specifically, Johnson and 
colleagues have shown that EFL does not appear until peak exercise, even when EFL was 
impending at moderate to heavy intensities. With impending EFL, DH occurs, and 
subjects breathe at a higher lung volume to meet the metabolic demands of heavy 
exercise. Johnson and colleagues reported that participants hyperventilated when 
breathing at higher lung volumes, exacerbating the mechanical constraint. Endurance 
trained athletes have an increased ventilatory requirement during exercise than non-
trained counterparts due to higher achievable workloads, which leads to mechanical 
constraints at peak exercise (Johnson et al. 1992). In the present study, we matched the 
ET and CON group for height and FVC, and EFL was still present in both groups, but 
with a much greater percentage and severity at peak exercise in the ET group. Therefore, 




higher in the ET compared to the CON group, there is likely still an anatomical limitation 
present during pubertal age or immediately post-puberty, which subjects may outgrow 
into adulthood. 
The present study found that there was no association between peak ventilation, 
dyspnea or RPE at peak exercise and severity of EFL. These findings are in agreement 
with that of Pianosi and colleagues (2019) who reported that youth and adolescent 
subjects exhibited EFL and dyspnea; however the degree of dyspnea was not associated 
with EFL or ventilation. Specifically, half of the subjects in their study cited difficulty 
breathing as their reason for stopping the exercise test. Several subjects that did not 
exhibit EFL still had dyspneic sensations that they cited as their primary reason for 
stopping the exercise test. In addition, dyspneic sensations have been reported to be 
higher when EFL is present, which may cause exercise intolerance (Stickland et al. 
2012). Therefore, it is not surprising that the subjects in the ET group had higher 
dyspneic sensations compared to the CON group, but it was surprising that there were no 
associations between dyspnea and severity of EFL in the ET group. 
Pulmonary Function  
The only pulmonary function outcome measurements that were different from 
pre- to post-exercise were FEF25-75%, of FVC, FEV1/FVC, and FEV1. Interestingly, FEV1 
was the only variable from the PFTs to have a significant difference among the groups 
across time, showing there was a difference in bronchodilation from pre- to post-exercise 
in the CON group when compared to the ET group. FEV1 typically increases post-
exercise due to an increase in cartilage stiffness with increased ventilation rates during 




interesting because typically with higher ventilation rates, there is greater post-exercise 
bronchodilation. While bronchodilation occurs in normal, healthy airways, exercise-
induced bronchoconstriction (EIB) occurs in approximately 10-50% of elite athletes 
depending on their sport and is especially common in athletes those who compete in 
national and international endurance events (Mohammadizadeh et al. 2013, Helenius et 
al. 1998). EIB is the narrowing of the large airways post-exercise and is caused by water 
loss from the airway membranes, which dries out the airways. Prolonged hyperventilation 
while training in conditions that expose endurance athletes to allergens and bronchial 
irritants during the exercise bout may increase EIB prevalence in an elite, endurance 
trained population (Helenius et al. 1998, 2000). Hyperventilation increases the pressure 
exerted on the airways and along with the lack of moisture, may cause damage to the 
airway’s epithelium. This damage then triggers the injury-repair process which can lead 
to bronchial hyper-responsiveness, typically seen 5-15 min post-exercise, yet is resolved 
within an hour post-exercise (Kippelen et al. 2012, Rundell et al. 2002, McFadden et al. 
1986). While EIB is typically reported in the 5-15 min post-exercise time period, 
bronchoconstriction has also been seen during exercise, which may impair exercise 
tolerance (Beck et al. 1994). In the present study, we only assessed pulmonary function 
pre- and post-exercise, and therefore it is difficult to determine whether the ET subjects 
were starting to exhibit or would have potentially had EIB. However, it is possible the 
individuals with the least amount of bronchodilation post-exercise could have had 
excessive drying of the airways, which is a cause of EIB, and this may have impacted 
exercise tolerance or post-exercise bronchodilation. 




An interesting finding in the present study was that there were no differences 
between groups in EELV across time-points, however there were increases in EILV, 
which is consistent with the previous literature. EILV increased steadily throughout the 
exercise test, similar to previous findings (Mota et al. 1999). In the present study, subjects 
that had flow limitation also showed DH, which explains the increase in EILV. 
Interestingly, the subjects in the CON group likely showed DH to avoid flow limitation, 
but may have reached volitional fatigue before having constrained ventilation due to 
EFL. Therefore, it is possible that with impending EFL, subject’s lungs began to 
hyperinflate, but ventilation did not need to reach high enough rates to be limited by their 
morphology. This may also explain why ventilation was not associated with EFL severity 
in flow-limited subjects (with CON and ET subjects combined). Whether DH occurs with 
impending EFL or when EFL first occurs still remains to be elucidated. The present 
findings for EELV are not in agreement with the majority of the current literature. Mota 
et al reported that EELV decreased during moderate intensity exercise by 13%, but then 
increased as they approached peak exercise due to DH, however their subjects exhibited 
EFL when DH occurred. Since the ET showed a high prevalence of EFL in the present 
study, the degree of DH was likely so high that significant changes in EELV were not 
present, even with much greater tidal volumes. In addition, the CON group experienced 
DH, but presumably did not achieve high enough workloads and ventilation rates to be 
flow-limited.   
Limitations 
 The primary limitation of this project is that we did not account for thoracic gas 




previous studies using independent measurements of transpulmonary pressures during 
expiration report a close agreement with the severity of EFL between methodologies 
(Johnson et al. 1991). Unfortunately, we were not able to obtain maturation status via 
Tanner Stages, and therefore were only able to match for age, FVC, and height. Due to 
their ages, it is likely that they are of nearing the end of puberty but are still considered 
youth. Also, this study also did not include female endurance athletes. Due to females 
having a higher prevalence of EFL and varying dysynapsis ratios (airway size relative to 
lung size), we cannot generalize our findings to the entire population of elite youth 
cyclists of both sexes. Finally, future studies should assess pulmonary function pre- and 
post-exercise, as well as 5, 10, and 30 min post-exercise to better understand airway 
function relative to ventilation rates and EFL severity.  
Future Directions 
 Since the prevalence of EFL differs between the sexes, assessment of the 
prevalence and severity of EFL in an elite endurance trained female population should be 
conducted. Also, it would be interesting to elucidate the prevalence and severity of EIB in 
elite endurance youth of both sexes since the current data in adolescents is scarce. 
Perhaps the most interesting area for future research is to assess whether the ET cyclists 
in the current study outgrow their flow limitation, or remain flow limited into adulthood, 
which would provide important longitudinal data on the pulmonary system limitations to 
exercise throughout the lifespan.  
Conclusions  
 This is the first study, to our knowledge, to investigate and identify a high  




Also, ET athletes have significantly greater EFL severity compared to recreationally 
active, untrained CON subjects matched for age, height and FVC. Whether or not these 
specific athletes will outgrow their flow limitation into adulthood is an interesting area 
for future research to better understand the development of the pulmonary system, as well 



















Figure 1. Severity of EFL during exercise for the ET and CON groups. Severity of EFL 
across VO2 values (x-error bars included to represent ranges) for the ET (open circles) 
and CON (closed circles) groups. There was significantly greater EFL severity in both 
groups from baseline to VO2peak (p<0.001). Compared to the CON group, the ET group 
experienced an even greater severity of EFL at peak exercise (p=0.004). *Significantly 
different from CON group. 
Figure 2. Operating lung volumes during exercise for ET and CON groups. Operating 
lung volumes across VO2 values (x-error bars included to represent ranges) for the ET 
(open circles)  and CON (closed circles) groups. EELV did not change across time or 
between groups (p>0.05). EILV increased in both group (p<0.05), however was not 
different between the ET and CON groups. *Significantly different in ET and CON from 
baseline to VO2peak (p<0.05). 
Figure 3a. Peak Ve as EFL severity in flow-limited subjects. There were 11 flow-limited 
subjects in the ET group and 5 subjects in the CON group).  
Figure 3b. Dyspnea and EFL severity in flow-limited subjects. 






Values are mean ± SD. 




































Values are mean ± SD. VO2, Oxygen consumption; VCO2, carbon dioxide 
produced; VE, ventilation; RPE, Rating of Perceived Exertion; RER, 
respiratory exchange ratio; VE/CO2, ventilatory equivalent for VCO2; 
VE/VO2, ventilatory equivalent for VO2; EELV, end expiratory lung 
volume; EILV, end inspiratory lung volume; EFL, expiratory flow 
limitation. 
















Values are mean ± SD. PEF, peak expiratory flow; FVC, forced vital 
capacity; FEV1, forced expiratory volume in 1 second; FEV1/FVC, forced 
expiratory volume in 1 second/forced vital capacity; FEF25-75%, forced 
expiratory flow at 25-75% of pulmonary volume. 
a Significantly different between ET and CON from pre- to post-

































































Figure 3a. Peak VE as EFL severity in flow-limited subjects. There were 11 flow-limited 
subjects in the ET group and 5 subjects in the CON group.
 
Figure 3b. Dyspnea and EFL severity in flow-limited subjects. 
 













Respiratory responses to exercise and prevalence of expiratory flow 
limitation in adolescent endurance athletes and untrained controls. 
 
Parent/Guardian Informed Consent 
 
IRB #18-0548 
Identification of Investigators & Purpose of Study   
Your child is being asked to participate in a research study conducted by Dr. Stephanie 
Kurti, Dr. Mike Saunders, Dr. Nick Luden, and Katherine Smith from James Madison 
University (JMU).  The purpose of this study is to examine respiratory responses to 
exercise in endurance trained adolescent cyclists and recreationally active, untrained 
adolescent subjects.  
 
Research Procedures 
Should you decide to allow your child to participate in this research study, you will be 
asked to sign this consent form once all your questions have been answered to your 
satisfaction.   
 
By participating in this study, the researchers will ask your child to perform (1) a body 
composition assessment, (2) a series of pulmonary function tests, (3) an exercise testing 
protocol and (4) a series of questionnaires. Each step is outlined in detail below. 
Additionally, to participate in the research, your child must be healthy and not diagnosed 
with any cardiovascular (i.e. heart murmur, aortic stenosis, unstable angina, active 
endocarditis, acute myocarditis, hypertension), pulmonary (i.e. obstructive or restrictive 
diseases), or metabolic diseases (i.e., type 1 and type 2 diabetes, insulin resistance, 
hyper/hypothyroidism); or any other diseases in these categories that are included in the 
American College of Sports Medicine guidelines. 
  
1) Body composition assessment: 
When your child first arrives to the laboratory, height, weight and body composition will 
be assessed. A DEXA analysis will be performed for body composition assessment. For 
the DEXA procedure, your child will be asked to lie down on their back and remain still 
for approximately 5-10 minutes until the scan is completed. All body composition 
assessment will be performed according to the American College of Sports Medicine 
guidelines. 
 
2) Pulmonary Function Testing: 
Following body composition assessment, your child will be asked to undergo standard 
pulmonary function testing according to the American Thoracic Society guidelines. 
Duration for the tests are dependent on the effort of your child and how quickly they 
learn to adequately perform the tests. Therefore, the duration of pulmonary function 
testing will be approximately 20-30 minutes total. These tests include nitrogen washout 
to assess total lung capacity (TLC). For this test, your child will simply breathe into a 
mouthpiece attached to the metabolic cart for ~7 minutes with a nose-clip on. After this, 
your child will perform the maximum flow-volume loop, where your child will be asked 




empty their lungs and hold it for 6 seconds, followed by another maximum inhale. Next, 
your child will be asked to perform a maximal exhale, maximal inhale and then be asked 
to hold their breath for approximately 5 seconds, and then asked to perform another 
exhale. This test measures the diffusion capacity of the lung. The next respiratory test 
will be a test in which your child will maximally exhale and inhale against a closed valve 
to measure maximum inspiratory and expiratory pressures. Every pulmonary function test 
is non-invasive and only involves various breathing maneuvers. 
 
3) Exercise Testing:  
Your child will then perform an incremental exercise test until volitional fatigue. The 
exercise testing protocol will take approximately 15-20 minutes from start to complete. 
This test simply requires your child to start pedaling a bike at 50 watts (if recreationally 
active) or self-selected watts (if endurance trained in cycling) and increase the watts by 
25 every 3 minutes until lactate threshold is reached. For lactate threshold, your child will 
undergo a finger stick at the end of every three-minute stages (typically three in total). 
When a specific blood lactate is reached, your child will undergo 1 minute stages 
increasing 25 watts/minute until volitional fatigue, or until they cannot turn the pedals 
anymore and choose to stop the test. Before and after the exercise test your child will 
complete several of the standard pulmonary function assessments described above.  
Time Required 
Participation in this study will require one session that will be approximately two hours in 




The investigators do not perceive more than minimal risks from your child’s involvement 
in this study (that is, no risks beyond the risks associated with everyday life).  Any 
potential risks associated with the testing itself were outlined in the consent forms for 
performance testing.  
 
Additionally, the DEXA scan entails a low dose of radiation equivalent to approximately 
one transatlantic flight (0.015 mSv= milliseievert). While there is no validated 
questionnaire to define extensive exposure, radiation exposure is cumulative (200 DEXA 
scans is equal to the cumulative exposure of living at sea level for a year (3 mSv)). 
DEXA scans carry minimal X-ray exposure.  To minimize exposure, the DEXA scan will 
only be performed once.  
Benefits 
1) The exercise test to volitional fatigue is the best indicator of overall health. This is an 
important and useful value for you and your child to be aware of. Additionally, we will 
let you know how he/she compared to individuals of the same age.  
2) The data obtained from this project will be used to better understand the responses of 
adolescent athletes to high-level endurance training.  Therefore, athletes may be able to 
use the data from this study to make well-informed decisions regarding your child’s 




3) This research study will give physiologists, clinicians and sports practitioners more 
information about lung function and limitations to exercise tolerance, which may lead to 
improved advice for youth athletes. 
 
It should be noted that while these are foreseeable benefits of your child’s participation in 
the study, they are not guaranteed.  
Payment for participation 
There is no payment for taking part in this study.    
Confidentiality  
The results of this research will be presented in classroom presentations, conferences and 
research journals.  Your child will be identified in the research records by a code name or 
number. The researchers retain the right to use and publish non-identifiable data.  When 
the results of this research are published or discussed in conferences, no information will 
be included that would reveal your child’s identity.  All data will be stored in a secure 
location accessible only to the researchers.  All information that matches up individual 
respondents with their code number will be stored in a secure location separate from their 
data.   
There is one exception to confidentiality we need to make you aware of. In certain 
research studies, it is our ethical responsibility to report situations of child abuse, child 
neglect, or any life-threatening situation to appropriate authorities. However, we are not 
seeking this type of information in our study nor will you be asked questions about these 
issues. 
Participation & Withdrawal  
Your child’s participation is entirely voluntary.  He/she is free to choose not to 
participate.  Should you and your child choose to participate, he/she can withdraw at any 
time without consequences of any kind. 
Questions about the Study 
If you have questions or concerns during the time of your child’s participation in this 
study, or after its completion or you would like to receive a copy of the final aggregate 
results of this study, please contact Dr. Stephanie Kurti at kurtisp@jmu.edu and (630) 
205- 6363, Dr. Mike Saunders at saundemj@jmu.edu and (540) 568-8121, Dr. Nicholas 
Luden at ludennd@jmu.edu and (540) 568-4069.   
 
For any questions about Your Rights as a Research Subject, please contact Dr. David 
Cockley:  
Chair, Institutional Review Board, James Madison University, (540) 568-2834, 
cocklede@jmu.edu 
Giving of Consent 
I have read this consent form and I understand what is being requested of my child as a 




satisfactory answers to my questions.  The investigator provided me with a copy of this 
form.  I certify that I am at least 18 years of age. 
 
______________________________________    ______________ 
Name of Child (Signed)                                           Date 
 
______________________________________    ______________ 
Name of Parent/Guardian (Printed)                          Date 
 
______________________________________    ______________ 
Name of Parent/Guardian (Signed)                          Date 
______________________________________    ______________ 








Respiratory responses to exercise and prevalence of expiratory flow 
limitation in adolescent endurance athletes and untrained controls. 
 
We are inviting you to participate in this study because you are either a recreationally 
active adolescent individual, or currently are an endurance trained adolescent cyclist. We 
are interested in studying how your lung and airways responds to exercise, and may 
possibly limit your exercise ability.  
 
By participating in this study, the researchers will ask you to perform (1) a body 
composition assessment, (2) a series of pulmonary function tests, (3) an exercise testing 
protocol and (4) a series of questionnaires. Each step is outlined in detail below. 
Additionally, you are not allowed to participate in this research study if you have been 
diagnosed with any cardiovascular, respiratory, or metabolic diseases. We will ensure 
with your parents that you have not been diagnosed with any of these types of diseases.   
 
1) Body composition assessment: 
When you first arrive to the laboratory, height, weight and body composition will be 
assessed. An analysis will be formed for body composition assessment (fat mass and lean 
muscle mass). To minimize exposure, the scan will only be performed once. For the 
DEXA procedure, you will be asked to lie down on your back and remain still for 
approximately 5-10 minutes until the scan is completed. All body composition 
assessment will be performed according to the American College of Sports Medicine 
guidelines. 
 
2) Pulmonary Function Assessment: 
Following body composition assessment, you will be asked to undergo standard 
pulmonary function testing (to test how your lungs function) according to the American 
Thoracic Society guidelines. Tests are dependent on your effort and how quickly you 
learn to adequately perform the tests. Therefore, the duration of pulmonary function 
testing will be approximately 20-30 minutes total. These tests include a test where we can 
first measure the total capacity of your lungs. For this test, you will simply breathe into a 
mouthpiece attached to the metabolic cart for ~7 minutes with a nose-clip on. After this, 
you will perform a test where you will be asked to perform a maximal inhale followed by 
a exhale where you will be asked to completely empty your lungs and hold it for 6 
seconds, followed by another maximum inhale. Next, you will be asked to perform a 
maximal exhale, maximal inhale and then be asked to hold your breath for approximately 
5 seconds, and then asked to perform another exhale. This test measures the diffusion 
capacity of your lung. The next respiratory test will be a test in which you will maximally 
exhale and inhale against a closed valve to measure maximum inspiratory and expiratory 
pressures. Every pulmonary function test is non-invasive and only involves various 
breathing maneuvers.  
 




You will then perform an incremental exercise test until volitional fatigue. The test 
duration is only about 15-20 minutes from start to finish. This test simply requires you to 
start pedaling a bike at 50 watts (if recreationally active) or self-selected watts (if 
endurance trained in cycling) and increase the watts by 25 every 3 minutes until lactate 
threshold is reached. For lactate threshold, you will undergo a finger stick at the end of 
every three-minute stages (typically three in total). When a specific blood lactate is 
reached, you will undergo 1 minute stages increasing 25 watts/minute until volitional 
fatigue, or until you cannot turn the pedals anymore and choose to stop the test. Before 
and after the exercise test you will complete the standard pulmonary function assessment 
described above.  
 
Your individual data will be completely confidential.  No information will be revealed in 
presentations or publications of the data that will reveal your identity.   
 
We have asked your parents for their permission for you to do this study. Please talk this 
over with them before you decide whether or not to participate by completing the 
performance testing and all questionnaires. 
 
If you have any questions at any time, please ask one of the researchers. 
 
If you check "yes," it means that you have decided to participate and have read 
everything that is on this form. You and your parents will be given a copy of this form to 
keep. 
 
______ Yes, I would like to participate in the study. 
 
_______________________________________________ ___________________ 
Signature of Subject Date 
 
_______________________________________________ ___________________ 
Signature of Investigator Date 
 
If you have any questions or concerns, please contact Dr. Stephanie Kurti at 
kurtisp@jmu.edu and (630) 205-6363, Dr. Mike Saunders at saundemj@jmu.edu at (540) 















Respiratory responses to exercise and prevalence of expiratory flow 
limitation in adolescent endurance athletes and untrained controls. 
 
Informed Consent (18 years of age and older) 
 
IRB #18-0548 
Identification of Investigators & Purpose of Study   
You are being asked to participate in a research study conducted by Dr. Stephanie Kurti, 
Dr. Mike Saunders, Dr. Nick Luden, and Katherine Smith from James Madison 
University (JMU).  The purpose of this study is to examine respiratory responses to 
exercise in endurance trained adolescent cyclists and recreationally active, untrained 
adolescent subjects. Additionally, to participate in the research, you must be healthy and 
not diagnosed with any cardiovascular (i.e. heart murmur, aortic stenosis, unstable 
angina, active endocarditis, acute myocarditis, hypertension), pulmonary (i.e. obstructive 
or restrictive diseases), or metabolic diseases (i.e., type 1 and type 2 diabetes, insulin 
resistance, hyper/hypothyroidism); or any other diseases in these categories that are 




Should you decide to participate in this research study, you will be asked to sign this 
consent form once all your questions have been answered to your satisfaction.   
 
By participating in this study, the researchers will ask you to perform (1) a body 
composition assessment, (2) a series of pulmonary function tests, (3) an exercise testing 
protocol and (4) a series of questionnaires. Each step is outlined in detail below.  
  
1) Body composition assessment: 
When you first arrive to the laboratory, height, weight and body composition will be 
assessed. A DEXA analysis will be performed for body composition assessment. For the 
DEXA procedure, you will be asked to lie down on their back and remain still for 
approximately 5-10 minutes until the scan is completed. All body composition 
assessment will be performed according to the American College of Sports Medicine 
guidelines. 
 
2) Pulmonary Function Testing: 
Following body composition assessment, you will be asked to undergo standard 
pulmonary function testing according to the American Thoracic Society guidelines. 
Duration for the tests are dependent on you effort how quickly you learn to adequately 
perform the tests. Therefore, the duration of pulmonary function testing will be 
approximately 20-30 minutes total. These tests include nitrogen washout to assess total 
lung capacity (TLC). For this test, you will simply breathe into a mouthpiece attached to 
the metabolic cart for ~7 minutes with a nose-clip on. After this, you will perform the 
maximum flow-volume loop, where you will be asked to perform a maximal inhale 
followed by a exhale where you will be asked to completely empty their lungs and hold it 




a maximal exhale, maximal inhale and then be asked to hold your breath for 
approximately 5 seconds, and then asked to perform another exhale. This test measures 
the diffusion capacity of the lung. The next respiratory test will be a test in which you 
will maximally exhale and inhale against a closed valve to measure maximum inspiratory 
and expiratory pressures. Every pulmonary function test is non-invasive and only 
involves various breathing maneuvers. 
 
3) Exercise Testing:  
You will then perform an incremental exercise test until volitional fatigue. The exercise 
testing protocol will take approximately 15-20 minutes from start to complete. This test 
simply requires you to start pedaling a bike at 50 watts (if recreationally active) or self-
selected watts (if endurance trained in cycling) and increase the watts by 25 every 3 
minutes until lactate threshold is reached. For lactate threshold, you will undergo a finger 
stick at the end of every three-minute stages (typically three in total). When a specific 
blood lactate is reached, you will undergo 1 minute stages increasing 25 watts/minute 
until volitional fatigue, or until you cannot turn the pedals anymore and choose to stop 
the test. Before and after the exercise test you will complete several of the standard 
pulmonary function assessments described above.   
Time Required 
Participation in this study will require one session that will be approximately two hours in 




The investigators do not perceive more than minimal risks from your involvement in this 
study (that is, no risks beyond the risks associated with everyday life).  Any potential 
risks associated with the testing itself were outlined in the consent forms for performance 
testing.  
 
Additionally, the DEXA scan entails a low dose of radiation equivalent to approximately 
one transatlantic flight (0.015 mSv= milliseievert). While there is no validated 
questionnaire to define extensive exposure, radiation exposure is cumulative (200 DEXA 
scans is equal to the cumulative exposure of living at sea level for a year (3 mSv)). 
DEXA scans carry minimal X-ray exposure.  To minimize exposure, the DEXA scan will 
only be performed once.  
Benefits 
1) The exercise test to volitional fatigue is the best indicator of overall health. This is an 
important and useful value for you to be aware of. Additionally, we will let you know 
how you compared to individuals of the same age.  
2) The data obtained from this project will be used to better understand the responses of 
adolescent athletes to high-level endurance training.  Therefore, athletes may be able to 
use the data from this study to make well-informed decisions regarding your future 




3) This research study will give physiologists, clinicians and sports practitioners more 
information about lung function and limitations to exercise tolerance, which may lead to 
improved advice for youth athletes. 
Payment for participation 
There is no payment for taking part in this study.    
Confidentiality  
The results of this research will be presented in classroom presentations, conferences and 
research journals.  You will be identified in the research records by a code name or 
number. The researchers retain the right to use and publish non-identifiable data.  When 
the results of this research are published or discussed in conferences, no information will 
be included that would reveal your identity.  All data will be stored in a secure location 
accessible only to the researchers.  All information that matches up individual 
respondents with their code number will be stored in a secure location separate from their 
data.   
There is one exception to confidentiality we need to make you aware of. In certain 
research studies, it is our ethical responsibility to report situations of child abuse, child 
neglect, or any life-threatening situation to appropriate authorities. However, we are not 
seeking this type of information in our study nor will you be asked questions about these 
issues. 
Participation & Withdrawal  
Your participation is entirely voluntary.  You are free to choose not to participate.  
Should you choose to participate, you can withdraw at any time without consequences of 
any kind. 
Questions about the Study 
If you have questions or concerns during the time of your participation in this study, or 
after its completion or you would like to receive a copy of the final aggregate results of 
this study, please contact Dr. Stephanie Kurti at kurtisp@jmu.edu and (630) 205- 6363, 
Dr. Mike Saunders at saundemj@jmu.edu and (540) 568-8121, Dr. Nicholas Luden at 
ludennd@jmu.edu and (540) 568-4069.   
 
For any questions about Your Rights as a Research Subject, please contact Dr. David 
Cockley:  
Chair, Institutional Review Board, James Madison University, (540) 568-2834, 
cocklede@jmu.edu 
Giving of Consent 
I have read this consent form and I understand what is being requested of me as a 
participant in this study.  I freely consent to participate.  I have been given satisfactory 
answers to my questions.  The investigator provided me with a copy of this form.  I 





______________________________________    ______________ 
Name of Participant (Signed)                                           Date 
______________________________________    ______________ 
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